Indegene streamlined patient enrollment for a large pharmaceutical organization in the US, improving drug access for patients with limited treatment options and achieving 90% faster onboarding while reducing abandoned enrollments by 45%. The existing offline, paper-driven consent process caused inefficiencies, costly delays, and high cancellations. Indegene's innovative software introduced a paperless, automated platform that enhanced information capture, consent management, and sent automated email/text reminders. This accelerated enrollment, minimized drop-offs, and optimized support program efficiency significantly.

Join for free to read